news, journals and articles from all over the world.
In a clinical trial led by Yale Cancer Center (YCC) and Smilow Cancer Hospital, researchers aim to exploit DNA mutations in the treatment of two blood and bone marrow cancers, a different tacit than the more traditional approach of blunting or switching off genetic mutations linked to cancer
The findings, published in British Journal of Cancer, were discovered by Professor Maria Kavallaris and her team could potentially lead to new treatment
New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for children and young adults with high- or intermediate-risk B-cell acute lymphoblastic leukemia (B-ALL) that has relapsed. Those treated with blinatumomab…
Bethesda, MD (Dec. 6, 2019) — Gastric intestinal metaplasia (GIM), which is linked to non-cardia gastric cancer, is often detected during routine endoscopy, leading to questions about how patient care should be managed. A new clinical guideline1 from the American…
Recommendations define how and when radiation therapy should be used to treat the most common types of skin cancer
Hollings Cancer Center researchers explore how to help the 60 percent of patients with TNBC who do not respond well to more traditional treatments
Mayo Clinic researchers will present findings at the American Society of Hematology Annual Meeting Dec. 7–10 in Orlando.
New Mayo Clinic studies to be presented include:
DNA analysis identifies elevated risk factor for myeloma in individuals of African ancestry
Study identifies more precise assessment measures for patients newly diagnosed with chronic lymphocytic leukemia
Researchers develop method to assess cancer-fighting cell therapy’s effectiveness
UT Southwestern researchers have developed a software tool that uses artificial intelligence to recognize cancer cells from digital pathology images – giving clinicians a powerful way of predicting patient outcomes.
A new study by Yale Cancer Center (YCC) researchers shows understanding treatment patterns for patients with acute myeloid leukemia (AML) is vital to develop strategies to improve outcomes.
A new study by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers suggests that the drug venetoclax aids therapy for relapsed/refractory myelodysplastic syndromes, especially when paired with azacytidine.
A new study from scientists at UCLA helps explain why some people with advanced cancer may not respond to one of the leading immunotherapies, PD-1 blockade, and how a new combination approach may help overcome resistance to the immunotherapy drug.
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine . The summaries are not intended to substitute for the full articles as a source of information. This information is…
Orlando FL. – December 9, 2019 – Scientists will present more than 40 abstracts highlighting research driven in part by Bio-Rad Laboratories’ Droplet Digital PCR (ddPCR) technology at the 2019 American Society of Hematology (ASH) meeting in Orlando Florida, December…
Post-transplant treatment with cyclophosphamide reduces rates of acute GVHD and relapse
Within weeks, CAR T cells targeting ovarian cancer cleared tumors in 70% of treated mice, shows study in Nature Biomedical Engineering (Note: Images available for media use)
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine . The summaries are not intended to substitute for the full articles as a source of information. This information is…
Orlando FL. – December 9, 2019 – Scientists will present more than 40 abstracts highlighting research driven in part by Bio-Rad Laboratories’ Droplet Digital PCR (ddPCR) technology at the 2019 American Society of Hematology (ASH) meeting in Orlando Florida, December…
Post-transplant treatment with cyclophosphamide reduces rates of acute GVHD and relapse
Within weeks, CAR T cells targeting ovarian cancer cleared tumors in 70% of treated mice, shows study in Nature Biomedical Engineering (Note: Images available for media use)
Use of next-generation sequencing provides evidence of no detectable lymphoma in these patients
Genomic profiles can be used to classify patients by risk of relapse after transplant
Trial is important step toward determining if this drug add-on can reduce risk of relapse in these patients
Identifying the type of pain an adult with sickle cell disease (SCD) experiences may be useful in improving treatment, according to a new study by researchers at Yale Cancer Center (YCC) and Smilow Cancer Hospital.
Patients who had acupuncture during radiation reported less dry mouth symptoms up to 12 months after treatment
“It is becoming clear that an acid extracellular pH plays an essential role in cancer cell progression, invasiveness and resistance to therapy,” explain Yuri Korchev and Yasufumi Takahashi at Nano Life Science Institute of Kanazawa University and Yanjun Zhang at…
UC San Diego launches new Center for Fluorescence-Guided Surgery. The center builds upon Roger Tsien’s legacy, delivering a new caliber of surgical precision to treat patients with tumors and disease of all types, identifying unhealthy tissues with a fluorescent glow.
Scientists from 22 institutions, including UCLA, are recommending early diagnosis, prevention and treatment of severe chronic inflammation to reduce the risk of chronic disease and death worldwide.
Shoghag Panjarian, PhD, a research scientist at the Coriell Institute for Medical Research, has been awarded a grant from the W. W. Smith Charitable Trust to support her search for epigenetic factors that contribute to the development and growth of breast cancer.
Research from doctors at The Ohio State University Wexner Medical Center finds a new “virtual biopsy” allows them to definitively diagnose cysts in the pancreas with unprecedented accuracy. This means they can eliminate precancerous cysts and potentially save lives. The…
In the United States, apart from some forms of skin cancer, breast cancer is the most common cancer in women. It is also the most common cause of death from cancer among Hispanic women and the second most common among…
Researchers at Goethe University develop new protoeomics procedure
What The Study Did: For patients with HIV, CD4 counts reflect the health of their immune system and HIV RNA levels indicate their viral load. This observational study focused on how cancer treatments were associated with those two important clinical…
Research from doctors at The Ohio State University Wexner Medical Center finds a new “virtual biopsy” allows them to definitively diagnose cysts in the pancreas with unprecedented accuracy. This means they can eliminate precancerous cysts and potentially save lives. The…
A person’s risk of developing cancer is affected by genetic variations in regions of DNA that don’t code for proteins, previously dismissed as ‘junk DNA’, according to new research published in the British Journal of Cancer today (Friday). This new…
The treatment takes place in 1 week or less
Accelerated partial breast irradiation although close was not equivalent to whole-breast irradiation to control ipsilateral breast tumor recurrence
Socioeconomic and healthcare delivery factors appear to contribute to the gap
In the United States, apart from some forms of skin cancer, breast cancer is the most common cancer in women. It is also the most common cause of death from cancer among Hispanic women and the second most common among…
Socioeconomic and healthcare delivery factors appear to contribute to the gap
Researchers at Goethe University develop new protoeomics procedure
What The Study Did: For patients with HIV, CD4 counts reflect the health of their immune system and HIV RNA levels indicate their viral load. This observational study focused on how cancer treatments were associated with those two important clinical…
What do you do when your best friend is diagnosed with a cancer that kills most of its patients within a few months? A few brave dog owners turned to Johns Hopkins, where veterinarians, radiologists and physicists have teamed up to conduct an experimental trial of a therapy they hope will extend the lives of their beloved pets.
Research from doctors at The Ohio State University Wexner Medical Center finds a new “virtual biopsy” allows them to definitively diagnose cysts in the pancreas with unprecedented accuracy. This means they can eliminate precancerous cysts and potentially save lives.
Researchers are still trying to find ways of catching pancreatic cancer early – or better yet, preventing it altogether. Meantime, here’s what patients need to know.
Grant seeks to support patient-centric research through funding and access to real-world oncology dataset
Researcher honored for major contributions to the field of melanoma research
Vienna, Austria – 4 December 2019: Cancer patients receiving common heart drugs have less heart damage from cancer therapy, according to research presented today at EuroEcho 2019, a scientific congress of the European Society of Cardiology (ESC).1 For every ten…
Abatacept, currently used for arthritis, gains FDA Breakthrough Therapy Designation for acute GVHD prevention
City of Hope co-led a phase 3 clinical trial that may soon change how renal cell carcinoma patients are treated in third- and fourth-line therapies
New study finds stronger alcohol regulations may be promising means of reducing cancer deaths
English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu